Foresite Capital Management V, LLC Compass Therapeutics, Inc. Transaction History

Foresite Capital Management V, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.87 - $3.25 $144,165 - $250,555	-77,094 Reduced 5.82%	1,246,977 $2.46 Million
Q2 2023 Aug 11, 2023	SELL	$2.64 - $3.48 $5.69 Million - $7.51 Million	-2,156,652 Reduced 61.96%	1,324,071 $4.21 Million
Q1 2023 May 12, 2023	SELL	$3.14 - $5.48 $2.89 Million - $5.04 Million	-919,277 Reduced 20.89%	3,480,723 $11.4 Million
Q4 2021 Feb 11, 2022	BUY	$2.88 - $3.98 $12.7 Million - $17.5 Million	4,400,000 New	4,400,000 $13.9 Million

91.9M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $139M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management V, LLC with notifications on news.